Thessaloniki, Greece
September 27, 2005
This was an educational programme created to encourage the dissemination of scientific knowledge in the field of MS. It stressed the benefits of new diagnostic tools for defining the natural history of MS and disease activity monitoring. Current diagnostic criteria for MS was also reviewed in light of new medical evidence. A review of recent clinical trials and treatment optimization guidelines was also presented.
OBJECTIVES
At the conclusion of this course the participant was able to:
- Explain the current diagnostic criteria for MS and the possible extensions.
- Assess the importance of genetic risk factors versus environmental triggers in the development of MS.
- Describe the benefits of new diagnostic tools, such as MRI or biological markers, in defining the natural history of MS and monitoring disease activity.
- Demonstrate competency in the basic concepts of treatment optimization.
TARGET AUDIENCE
This programme was appropriate for all clinicians and scientists who are interested in Multiple Sclerosis.
Serono Symposia International Foundation (www.seronosymposia.org) will submit this programme “MS Academia” (September 27, 2004, Thessaloniki, Greece) for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME).
This programme “MS Academia” (September 27, 2004, Thessaloniki, Greece) will be submitted for CME accreditation from the Italian Ministry of Health.
